Epirubicin and Cyclophosphamide-induced Acute Fibrinous and Organizing Pneumonia.

Naraoka, Taeka; Sumi, Toshiyuki; Keira, Yoshiko; Nakata, Hisashi; Chiba, Hirofumi

Naraoka, Taeka; Sumi, Toshiyuki; Keira, Yoshiko; Nakata, Hisashi; Chiba, Hirofumi.

Naraoka T; Department of Pulmonary Medicine and.
Sumi T; Department of Pulmonary Medicine and.
Keira Y; Department of Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, Sapporo, Japan.
Nakata H; Department of Surgical Pathology, Hakodate Goryoukaku Hospital, Hakodate, Japan; and.
Chiba H; Department of Pulmonary Medicine and.

Am J Respir Crit Care Med ; 204(8): e92-e93, 2021 10 15.

Article in English | MEDLINE | ID: covidwho-1495778

Subject(s)

Antibiotics, Antineoplastic/adverse effects; Antineoplastic Agents, Alkylating/adverse effects; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Cryptogenic Organizing Pneumonia/chemically induced; Cyclophosphamide/adverse effects; Epirubicin/adverse effects; Acute Disease; Cryptogenic Organizing Pneumonia/diagnostic imaging; Cryptogenic Organizing Pneumonia/pathology; Fatal Outcome; Female; Humans; Middle Aged; Tomography, X-Ray Computed

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Epirubicin / Antineoplastic Combined Chemotherapy Protocols / Cryptogenic Organizing Pneumonia / Antineoplastic Agents, Alkylating / Cyclophosphamide / Antibiotics, Antineoplastic Type of study: Case report / Prognostic study Topics: Variants Limits: Female / Humans / Middle aged Language: English Journal: Am J Respir Crit Care Med Journal subject: Critical Care Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google